22:37:55 EDT Sun 28 May 2023
Enter Symbol
or Name
USA
CA



MCI's Khure platform covers 110 AI algorithms

2023-02-07 14:11 ET - News Release

Dr. Alexander Dobranowski reports

MCI ONEHEALTH PROVIDES UPDATE ON SUBSIDIARY KHURE HEALTH

MCI Onehealth Technologies Inc. has provided news of a recently demonstrated positive impact on patient care from use of the technology platform provided by Khure Health, an MCI wholly owned subsidiary that provides AI-powered (artificial intelligence) clinical intelligence technology and services to physicians to support earlier diagnosis of rare diseases and now also chronic conditions.

Khure Health's clinical intelligence platform now supports physicians with over 110 rare and chronic disease-specific AI algorithms designed to help physicians save precious time and identify patients with potential risk of these complex diseases earlier in their disease progression to help physicians end their suffering and save lives.

Khure Health is pleased to announce its first peer-reviewed publication in The Canadian Journal of Kidney Health and Disease. "Impacting management of chronic kidney disease through primary care practice audits: A quality improvement study" by authors A. Mosa, D Watts, and N. Tangri.1

The paper summarizes the use of Khure's technology to compliantly screen 361,299 primary care electronic medical records, across 201 Ontario practices, which led to the identification of 8,194 patients with Stage 3 Chronic Kidney Disease at risk for progression or cardiovascular events. From these at-risk patients, 2,010 individuals (10 patients per practice) at high or moderate risk were selected by the physician for a chart audit via Khure Health's clinical platform. Physicians then made clinical decisions regarding appropriate additional testing or prescription of disease-modifying therapy, which occurred in 24% of these patients. The paper concludes that an AI-enabled EHR clinical decision support application can enable improved laboratory testing and management.

"Khure Health's mission is to help physicians identify rare, complex and chronic diseases earlier in their disease progression to end suffering and save lives. This paper demonstrates the validity of the Khure platform as much-needed support for overburdened doctors, helping them immediately optimize the care of their patients at risk of rare, complex and chronic disease," said Don Watts, President of Khure. "The patients who received care pathway changes from their physician as a result of the support our technology provided, may now have a better chance to slow their disease progression and perhaps not need dialysis or a kidney transplant in the future."

"We are very proud to be helping physicians make such a measurable impact for their patients. Early diagnosis and preventive care, through the use of advanced technology to support physicians, can not only help to support improved quality of life for patients, but if broadly deployed, can also help to save significant health system costs. We're excited to be rapidly scaling the deployment of Khure Health's clinical intelligence platform to primary care physicians and specialists across Canada and internationally," said

Dr. Alexander Dobranowski, MCI Onehealth CEO. "Khure's success is a key factor fueling MCI's accelerating growth in higher-margin, data-driven and clinical research initiatives that have direct benefit for patients."

About Khure Health

Khure Health has grown its business helping primary care physicians and specialists identify potential rare, complex and chronic disease patient risk within their practices. Khure's AI-enabled clinical intelligence platform allows healthcare practitioners to utilize the vast amounts of valuable clinical data sitting idle in their electronic health records to help identify potential opportunities to improve patient care and create healthcare system efficiencies for all stakeholders. By partnering with global pharmaceutical companies and patient advocacy groups, Khure Health develops advanced clinical algorithms to identify patients with potential risk or in need of care pathway optimization. Its cloud-based platform allows Khure to scale rapidly and to enter new geographic markets efficiently, as it recently did in entering the US market. Khure's, privacy regulation-compliant technology is also helping to accelerate clinical research and scientific discovery.

About MCI

MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. As part of the healthcare community for over 30 years, MCI operates one of Canada's leading primary care networks with approximately 280 physicians and specialists, serves more than one million patients annually and had nearly 300,000 telehealth visits last year, including online visits via mciconnect.ca . MCI additionally offers an expanding suite of occupational health service offerings that support a growing list of nearly 600 corporate customers. MCI provides data insights as a service in six categories: rare disease; complex major medical/chronic; patient cohort building; clinical trial recruitment; synthetic health data and bespoke insights. Led by a proven management team of doctors and experienced executives, MCI remains focused on executing a strategy centered around acquiring technology and health services that complement the company's current roadmap. For more information, visit mcionehealth.com.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.